News Focus
News Focus
Followers 22
Posts 748
Boards Moderated 0
Alias Born 09/07/2016

Re: jessellivermore post# 148978

Thursday, 10/11/2018 11:43:05 AM

Thursday, October 11, 2018 11:43:05 AM

Post# of 447254
JL- You and I agree on the science and the vlaue and the potential of V. The only place we differ is how fast we get there.

Things to consider are that insurance coverage takes time. I know in my state Vascepa requires a prior authorization for ANY use on the Medicaid formulary. There are lots of Mcaid recipients where V would be medically necesary but few docs will spend the extra 30 minutes filling out forms and fighting the beuracracy unless it's on the formulary - and that will take time.
Insures take time changing the tiers of prescriptions- this won't be immediate
80% of PCP's have never prescribed V and don't know what it is- Yes they will hear about RI but it will take time to understand and incorporate into their practices. They will end up being the biggest prescribers of V.

We will get there, but Standard of Care shifts in medicine where there has been little change in 30 years take time. Statins took 10+ years to gain acceptance. V will be faster than most changes because of the importance of the breakthrough but I believe investors in AMRN will require patience to reap the big rewards. We need to understand that to stay the course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News